SIMILAR PATTERNS OF AMINO ACIDS FOR 2O4P_A_TPVA300_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f1u HOMOPROTOCATECHUATE
2,3-DIOXYGENASE


(Arthrobacter
globiformis)
PF00903
(Glyoxalase)
5 ARG A 165
LEU A 122
ASP A 201
ILE A  15
GLY A 174
None
1.11A 2o4pA-1f1uA:
undetectable
2o4pA-1f1uA:
15.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
GLY A  48
PRO A  81
VAL A  82
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
0.89A 2o4pA-1hvcA:
14.2
2o4pA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ASP A  30
ILE A  84
A79  A 800 (-3.4A)
A79  A 800 ( 3.8A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.8A)
1.36A 2o4pA-1hvcA:
14.2
2o4pA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
A79  A 800 (-3.4A)
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
0.61A 2o4pA-1hvcA:
14.2
2o4pA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
A79  A 800 (-3.6A)
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
0.56A 2o4pA-1hvcA:
14.2
2o4pA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
A79  A 800 (-3.6A)
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 3.4A)
1.49A 2o4pA-1hvcA:
14.2
2o4pA-1hvcA:
48.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jax CONSERVED
HYPOTHETICAL PROTEIN


(Archaeoglobus
fulgidus)
PF03807
(F420_oxidored)
5 LEU A   5
ALA A  61
ASP A  60
ILE A  87
VAL A  69
None
1.08A 2o4pA-1jaxA:
undetectable
2o4pA-1jaxA:
16.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pqu ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Haemophilus
influenzae)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
5 LEU A 354
ALA A  98
ASP A  97
GLY A   8
VAL A  16
NAP  A1372 (-4.3A)
NAP  A1372 ( 4.0A)
None
NAP  A1372 (-3.1A)
None
0.95A 2o4pA-1pquA:
undetectable
2o4pA-1pquA:
15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rjb FL CYTOKINE RECEPTOR

(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 792
ILE A 921
GLY A 875
ILE A 876
PRO A 911
None
1.09A 2o4pA-1rjbA:
undetectable
2o4pA-1rjbA:
15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s2t PHOSPHOENOLPYRUVATE
PHOSPHOMUTASE


(Mytilus edulis)
PF13714
(PEP_mutase)
5 LEU A  71
ALA A  32
GLY A  42
ILE A  23
VAL A 108
None
0.87A 2o4pA-1s2tA:
undetectable
2o4pA-1s2tA:
19.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
0.59A 2o4pA-1sivA:
18.5
2o4pA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.42A 2o4pA-1sivA:
18.5
2o4pA-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sqj OLIGOXYLOGLUCAN
REDUCING-END-SPECIFI
C CELLOBIOHYDROLASE


(Geotrichum sp.
M128)
PF15899
(BNR_6)
5 ARG A 141
ASP A  89
ASP A  60
ILE A  56
ILE A  36
None
1.08A 2o4pA-1sqjA:
undetectable
2o4pA-1sqjA:
8.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t4b ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Escherichia
coli)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
5 LEU A 351
ALA A  97
ASP A  96
GLY A   8
VAL A  16
None
0.98A 2o4pA-1t4bA:
undetectable
2o4pA-1t4bA:
17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uaa PROTEIN
(ATP-DEPENDENT DNA
HELICASE REP.)


(Escherichia
coli)
PF00580
(UvrD-helicase)
PF13361
(UvrD_C)
5 LEU A 630
ALA A 596
ILE A 291
ILE A 283
PRO A 634
None
0.88A 2o4pA-1uaaA:
undetectable
2o4pA-1uaaA:
10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w6v UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 15


(Homo sapiens)
PF06337
(DUSP)
5 LEU A 100
ASP A  10
ASP A   8
GLY A  46
PRO A  62
None
1.06A 2o4pA-1w6vA:
undetectable
2o4pA-1w6vA:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wn1 DIPEPTIDASE

(Pyrococcus
horikoshii)
PF00557
(Peptidase_M24)
PF01321
(Creatinase_N)
5 LEU A 167
ILE A 182
GLY A 217
ILE A 227
VAL A 188
None
1.10A 2o4pA-1wn1A:
undetectable
2o4pA-1wn1A:
14.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
0.46A 2o4pA-2fmbA:
15.0
2o4pA-2fmbA:
31.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kho HEAT SHOCK PROTEIN
70


(Escherichia
coli)
PF00012
(HSP70)
5 ASP A 182
ILE A 169
GLY A 374
ILE A 373
VAL A 381
None
1.02A 2o4pA-2khoA:
undetectable
2o4pA-2khoA:
12.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mf2 MRNA INTERFERASE
MAZF


(Staphylococcus
aureus)
PF02452
(PemK_toxin)
5 LEU A 118
ASP A 115
ASP A 108
GLY A  17
ILE A  40
None
1.05A 2o4pA-2mf2A:
undetectable
2o4pA-2mf2A:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pnm PROTEASE VP4

(Infectious
pancreatic
necrosis virus)
PF01768
(Birna_VP4)
5 LEU A 560
ALA A 674
ILE A 668
GLY A 687
ILE A 686
None
1.05A 2o4pA-2pnmA:
undetectable
2o4pA-2pnmA:
23.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rgj FLAVIN-CONTAINING
MONOOXYGENASE


(Pseudomonas
aeruginosa)
PF01494
(FAD_binding_3)
5 LEU A 175
ALA A 311
ASP A 310
GLY A  11
ILE A   9
None
None
FAD  A 403 (-2.7A)
FAD  A 403 (-3.2A)
None
1.10A 2o4pA-2rgjA:
undetectable
2o4pA-2rgjA:
14.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
0.52A 2o4pA-2rkfA:
20.6
2o4pA-2rkfA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.44A 2o4pA-2rkfA:
20.6
2o4pA-2rkfA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 ARG A  10
LEU A  35
ASP A  37
ALA A  40
ASP A  41
None
0.82A 2o4pA-2rspA:
12.8
2o4pA-2rspA:
33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2va8 SKI2-TYPE HELICASE

(Sulfolobus
solfataricus)
PF00270
(DEAD)
PF00271
(Helicase_C)
5 ALA A 233
ASP A 232
GLY A 355
ILE A 354
VAL A 404
None
0.80A 2o4pA-2va8A:
undetectable
2o4pA-2va8A:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wlt L-ASPARAGINASE

(Helicobacter
pylori)
PF00710
(Asparaginase)
5 LEU A  73
ASP A  64
GLY A  15
ILE A  17
VAL A  57
None
None
ASP  A1333 (-3.2A)
None
None
0.86A 2o4pA-2wltA:
undetectable
2o4pA-2wltA:
16.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xrm INTRACELLULAR
SUBTILISIN PROTEASE


(Bacillus
clausii)
PF00082
(Peptidase_S8)
5 ASP A  49
ILE A 115
GLY A  46
ILE A 149
VAL A 167
None
1.09A 2o4pA-2xrmA:
undetectable
2o4pA-2xrmA:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yn9 POTASSIUM-TRANSPORTI
NG ATPASE ALPHA
CHAIN 1


(Sus scrofa)
PF00122
(E1-E2_ATPase)
PF00689
(Cation_ATPase_C)
PF00690
(Cation_ATPase_N)
PF09040
(H-K_ATPase_N)
PF13246
(Cation_ATPase)
5 ASP A 851
ASP A 779
ILE A 777
GLY A 377
PRO A 292
None
1.04A 2o4pA-2yn9A:
undetectable
2o4pA-2yn9A:
6.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ze4 PHOSPHOLIPASE D

(Streptomyces
antibioticus)
PF13091
(PLDc_2)
6 LEU A  36
ALA A 478
ASP A 450
ILE A 471
PRO A 265
VAL A 264
None
1.33A 2o4pA-2ze4A:
undetectable
2o4pA-2ze4A:
11.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a0f XYLOGLUCANASE

(Geotrichum sp.
M128)
no annotation 5 ARG A 146
ASP A  94
ALA A  65
ILE A  55
ILE A  35
None
1.06A 2o4pA-3a0fA:
undetectable
2o4pA-3a0fA:
7.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqc COMPONENT B OF
HEXAPRENYL
DIPHOSPHATE SYNTHASE


(Micrococcus
luteus)
PF00348
(polyprenyl_synt)
5 ASP B 211
ASP B 212
ILE B 167
GLY B 204
ILE B 203
MG  B 328 (-3.1A)
None
None
None
None
0.85A 2o4pA-3aqcB:
undetectable
2o4pA-3aqcB:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3axs PROBABLE
N(2),N(2)-DIMETHYLGU
ANOSINE TRNA
METHYLTRANSFERASE
TRM1


(Aquifex
aeolicus)
PF02005
(TRM)
5 LEU A  43
ASP A 132
GLY A  64
ILE A  68
VAL A  56
None
SFG  A 501 (-3.7A)
None
None
None
1.06A 2o4pA-3axsA:
undetectable
2o4pA-3axsA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fhh OUTER MEMBRANE HEME
RECEPTOR SHUA


(Shigella
dysenteriae)
PF00593
(TonB_dep_Rec)
PF07715
(Plug)
5 ARG A 415
LEU A 116
ASP A 479
GLY A 532
ILE A 541
None
1.09A 2o4pA-3fhhA:
undetectable
2o4pA-3fhhA:
12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gt7 SENSOR PROTEIN

(Syntrophus
aciditrophicus)
PF00072
(Response_reg)
5 ARG A 102
ALA A 108
ASP A 109
ILE A  59
VAL A  63
None
1.10A 2o4pA-3gt7A:
undetectable
2o4pA-3gt7A:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3imh GALACTOSE-1-EPIMERAS
E


(Lactobacillus
acidophilus)
PF01263
(Aldose_epim)
5 LEU A 127
ASP A 129
ILE A  72
GLY A 102
ILE A 103
None
1.04A 2o4pA-3imhA:
undetectable
2o4pA-3imhA:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3it4 ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ ALPHA CHAIN
ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ BETA CHAIN


(Mycobacterium
tuberculosis)
PF01960
(ArgJ)
5 ASP B 241
ILE A 130
GLY A 128
PRO A  64
VAL A  65
None
1.00A 2o4pA-3it4B:
undetectable
2o4pA-3it4B:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l2z BIRA BIFUNCTIONAL
PROTEIN


(Mycobacterium
tuberculosis)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
5 LEU A 153
ALA A 108
ASP A 111
ILE A 199
VAL A  86
None
1.03A 2o4pA-3l2zA:
undetectable
2o4pA-3l2zA:
17.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
VAL A  82
None
0.93A 2o4pA-3mwsA:
20.0
2o4pA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
PRO A  81
None
0.72A 2o4pA-3mwsA:
20.0
2o4pA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
0.61A 2o4pA-3mwsA:
20.0
2o4pA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
PRO A  81
VAL A  82
None
0.62A 2o4pA-3mwsA:
20.0
2o4pA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.40A 2o4pA-3mwsA:
20.0
2o4pA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
None
0.48A 2o4pA-3mwsA:
20.0
2o4pA-3mwsA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ooq AMIDOHYDROLASE

(Thermotoga
maritima)
PF01979
(Amidohydro_1)
5 ALA A 359
ASP A 358
ASP A 381
ILE A 380
GLY A  58
None
1.09A 2o4pA-3ooqA:
undetectable
2o4pA-3ooqA:
13.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pzr ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Vibrio cholerae)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
6 LEU A 351
ALA A  96
ASP A  95
ILE A  69
GLY A   7
VAL A  15
None
None
None
None
NAP  A 372 (-3.1A)
None
1.06A 2o4pA-3pzrA:
undetectable
2o4pA-3pzrA:
14.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
0.74A 2o4pA-3t3cA:
18.6
2o4pA-3t3cA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
017  A 201 ( 4.8A)
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
0.58A 2o4pA-3ttpA:
19.5
2o4pA-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
017  A 201 ( 4.8A)
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
1.46A 2o4pA-3ttpA:
19.5
2o4pA-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
017  A 201 ( 4.8A)
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-4.1A)
1.42A 2o4pA-3ttpA:
19.5
2o4pA-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.54A 2o4pA-3u7sA:
19.8
2o4pA-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
1.28A 2o4pA-3u7sA:
19.8
2o4pA-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  82
ASP A  30
ILE A  47
GLY A  49
ILE A  50
017  A 202 (-4.0A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.95A 2o4pA-3u7sA:
19.8
2o4pA-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
None
0.72A 2o4pA-3uhlA:
16.0
2o4pA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
None
0.42A 2o4pA-3uhlA:
16.0
2o4pA-3uhlA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uw3 ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Burkholderia
thailandensis)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
6 LEU A 355
ALA A  96
ASP A  95
ILE A  69
GLY A   7
VAL A  15
None
1.10A 2o4pA-3uw3A:
undetectable
2o4pA-3uw3A:
14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w2i NADH-CYTOCHROME B5
REDUCTASE 3


(Sus scrofa)
PF00175
(NAD_binding_1)
PF00970
(FAD_binding_6)
5 ASP A  72
ASP A  73
GLY A  43
ILE A   5
PRO A  36
None
0.96A 2o4pA-3w2iA:
undetectable
2o4pA-3w2iA:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a9a RIBOSOME-INTERACTING
GTPASE 1


(Saccharomyces
cerevisiae)
PF01926
(MMR_HSR1)
PF02824
(TGS)
PF16897
(MMR_HSR1_Xtn)
5 LEU A 145
ILE A 122
GLY A  72
ILE A 149
VAL A  68
None
0.92A 2o4pA-4a9aA:
undetectable
2o4pA-4a9aA:
14.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d1t METALLO-B-LACTAMASE

(Pseudomonas
aeruginosa)
PF00753
(Lactamase_B)
5 LEU A  96
ALA A  86
ILE A  56
GLY A  71
ILE A  83
None
0.83A 2o4pA-4d1tA:
undetectable
2o4pA-4d1tA:
18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dzh AMIDOHYDROLASE

(Xanthomonas
campestris)
PF01979
(Amidohydro_1)
5 ALA A 355
ILE A  25
GLY A 370
ILE A 369
VAL A 381
None
1.04A 2o4pA-4dzhA:
undetectable
2o4pA-4dzhA:
12.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ex9 ALNA

(Streptomyces
sp. CM020)
PF04227
(Indigoidine_A)
5 LEU A   9
ILE A  87
GLY A 108
ILE A 110
VAL A  68
None
1.03A 2o4pA-4ex9A:
undetectable
2o4pA-4ex9A:
14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fxp ADENYLYL-SULFATE
KINASE 1,
CHLOROPLASTIC


(Arabidopsis
thaliana)
PF01583
(APS_kinase)
5 ARG A 185
ASP A 187
ALA A 156
ASP A 154
PRO A 238
None
0.92A 2o4pA-4fxpA:
undetectable
2o4pA-4fxpA:
17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jn7 ENOLASE

(Agrobacterium
tumefaciens)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 LEU A  23
ILE A 266
GLY A 270
ILE A  86
VAL A  21
None
1.10A 2o4pA-4jn7A:
undetectable
2o4pA-4jn7A:
14.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jxy TRANS-HEXAPRENYLTRAN
STRANSFERASE


(Pseudoalteromonas
atlantica)
PF00348
(polyprenyl_synt)
5 LEU A 289
ASP A 211
ASP A 212
ILE A 167
GLY A 204
None
1.04A 2o4pA-4jxyA:
undetectable
2o4pA-4jxyA:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kkm POLYPRENYL
SYNTHETASE


(Zymomonas
mobilis)
PF00348
(polyprenyl_synt)
5 ALA A 224
ASP A 225
ASP A 226
GLY A 218
ILE A 217
None
0.95A 2o4pA-4kkmA:
undetectable
2o4pA-4kkmA:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4krg PHOSPHOETHANOLAMINE
N-METHYLTRANSFERASE
1


(Haemonchus
contortus)
PF08241
(Methyltransf_11)
5 LEU A  69
ASP A  57
ALA A  60
ASP A  80
ILE A  62
None
None
None
SAH  A 502 (-2.5A)
None
0.95A 2o4pA-4krgA:
undetectable
2o4pA-4krgA:
10.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
0.90A 2o4pA-4njvA:
20.9
2o4pA-4njvA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
RIT  A 500 (-3.2A)
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
0.69A 2o4pA-4njvA:
20.9
2o4pA-4njvA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
RIT  A 500 (-3.2A)
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
1.50A 2o4pA-4njvA:
20.9
2o4pA-4njvA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
RIT  A 500 (-3.2A)
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
0.56A 2o4pA-4njvA:
20.9
2o4pA-4njvA:
86.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4opf NRPS/PKS

(Streptomyces
albus)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 LEU A6257
ALA A6205
ASP A6208
ILE A6454
VAL A6223
None
0.99A 2o4pA-4opfA:
undetectable
2o4pA-4opfA:
14.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p2f ADENYLATE CYCLASE

(Mycobacterium
tuberculosis)
PF00211
(Guanylate_cyc)
5 ALA A 323
ASP A 325
GLY A 423
ILE A 422
VAL A 392
None
None
GOL  A 520 (-3.2A)
None
None
1.11A 2o4pA-4p2fA:
undetectable
2o4pA-4p2fA:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ry9 PERIPLASMIC BINDING
PROTEIN/LACI
TRANSCRIPTIONAL
REGULATOR


(Verminephrobacter
eiseniae)
PF13407
(Peripla_BP_4)
5 LEU A 105
ASP A  86
GLY A  39
ILE A  96
VAL A 109
None
1.05A 2o4pA-4ry9A:
undetectable
2o4pA-4ry9A:
15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ttp DEPHOSPHO-COA KINASE

(Legionella
pneumophila)
PF01121
(CoaE)
5 ALA A 175
ASP A 176
ASP A 177
GLY A  12
ILE A 118
None
0.81A 2o4pA-4ttpA:
undetectable
2o4pA-4ttpA:
15.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ttp DEPHOSPHO-COA KINASE

(Legionella
pneumophila)
PF01121
(CoaE)
5 LEU A 168
ALA A 175
ASP A 176
ASP A 177
ILE A 118
None
0.93A 2o4pA-4ttpA:
undetectable
2o4pA-4ttpA:
15.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xr9 CALS8

(Micromonospora
echinospora)
PF00984
(UDPG_MGDP_dh)
PF03720
(UDPG_MGDP_dh_C)
PF03721
(UDPG_MGDP_dh_N)
5 ASP A 369
ALA A 372
ASP A 373
PRO A 350
VAL A 351
None
1.07A 2o4pA-4xr9A:
undetectable
2o4pA-4xr9A:
13.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xvo L,D-TRANSPEPTIDASE

(Mycolicibacterium
smegmatis)
PF03734
(YkuD)
5 ASP A 107
ALA A  91
ASP A  88
ILE A  84
PRO A  63
None
1.00A 2o4pA-4xvoA:
undetectable
2o4pA-4xvoA:
17.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 ARG A  10
LEU A  30
ASP A  32
ALA A  35
ASP A  36
GLY A  58
None
None
4B1  A 201 (-2.9A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
0.63A 2o4pA-4ydfA:
13.0
2o4pA-4ydfA:
31.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a87 METALLO-BETA-LACTAMA
SE VIM-5


(Klebsiella
pneumoniae)
PF00753
(Lactamase_B)
5 LEU A  96
ALA A  86
ILE A  57
GLY A  71
ILE A  83
None
0.85A 2o4pA-5a87A:
undetectable
2o4pA-5a87A:
18.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
None
1.24A 2o4pA-5b18A:
18.2
2o4pA-5b18A:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bnt ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Pseudomonas
aeruginosa)
no annotation 5 LEU C 352
ALA C  97
ASP C  96
GLY C   8
VAL C  16
None
NAP  C 500 ( 4.2A)
None
NAP  C 500 (-3.2A)
None
1.04A 2o4pA-5bntC:
undetectable
2o4pA-5bntC:
16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cg0 BETA-GLUCOSIDASE

(Spodoptera
frugiperda)
PF00232
(Glyco_hydro_1)
5 LEU A 389
ALA A 282
GLY A 321
ILE A 279
PRO A 393
None
1.09A 2o4pA-5cg0A:
undetectable
2o4pA-5cg0A:
11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cuw SRTE1

(Streptomyces
coelicolor)
PF04203
(Sortase)
5 ALA A 237
GLY A 247
ILE A 315
PRO A 303
VAL A 302
None
1.07A 2o4pA-5cuwA:
undetectable
2o4pA-5cuwA:
18.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d01 N-ACETYL-ALPHA-D-GLU
COSAMINYL L-MALATE
SYNTHASE


(Bacillus
subtilis)
PF00534
(Glycos_transf_1)
PF13439
(Glyco_transf_4)
5 ARG A 147
ALA A  93
ILE A  79
GLY A   7
ILE A   6
None
1.11A 2o4pA-5d01A:
undetectable
2o4pA-5d01A:
13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dji 3'-PHOSPHOADENOSINE
5'-PHOSPHATE
PHOSPHATASE


(Mycobacterium
tuberculosis)
PF00459
(Inositol_P)
5 LEU A 247
ALA A 201
ASP A 200
ILE A 179
PRO A 167
None
1.04A 2o4pA-5djiA:
undetectable
2o4pA-5djiA:
18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e1b N-TERMINAL
XAA-PRO-LYS
N-METHYLTRANSFERASE
1


(Homo sapiens)
PF05891
(Methyltransf_PK)
5 LEU A  80
ASP A  67
ALA A  70
ASP A  91
ILE A  72
None
None
None
SAH  A 301 (-2.7A)
None
1.08A 2o4pA-5e1bA:
undetectable
2o4pA-5e1bA:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gle ISCHORISMATE LYASE

(Vibrio
anguillarum)
no annotation 5 LEU A  57
ALA A 176
ASP A 177
GLY A 172
ILE A 171
None
1.09A 2o4pA-5gleA:
undetectable
2o4pA-5gleA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lxz SECRETED PROTEIN

(Streptomyces
lividans)
PF07646
(Kelch_2)
PF09118
(DUF1929)
5 ASP B 428
ALA B 431
ASP B 432
ASP B 433
VAL B 437
None
1.04A 2o4pA-5lxzB:
undetectable
2o4pA-5lxzB:
10.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
0.58A 2o4pA-5t2zA:
20.0
2o4pA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
None
1.44A 2o4pA-5t2zA:
20.0
2o4pA-5t2zA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u2w SHORT CHAIN
DEHYDROGENASE


(Burkholderia
cenocepacia)
PF00106
(adh_short)
5 ALA A 170
ASP A 172
GLY A 164
ILE A 163
VAL A 137
None
1.04A 2o4pA-5u2wA:
undetectable
2o4pA-5u2wA:
15.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vc2 SERINE
HYDROXYMETHYLTRANSFE
RASE


(Helicobacter
pylori)
PF00464
(SHMT)
5 LEU A 195
ASP A 197
GLY A 234
ILE A 235
VAL A 102
None
1.10A 2o4pA-5vc2A:
undetectable
2o4pA-5vc2A:
13.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wu7 UNCHARACTERIZED
PROTEIN


(Pyrococcus
horikoshii)
PF03065
(Glyco_hydro_57)
PF09210
(DUF1957)
5 ALA A 259
ILE A 387
GLY A 180
ILE A 181
VAL A 222
None
1.00A 2o4pA-5wu7A:
undetectable
2o4pA-5wu7A:
10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xgv PYRE3

(Streptomyces
rugosporus)
no annotation 5 LEU A 155
ALA A 276
ASP A 275
GLY A  14
ILE A   7
FAD  A 501 ( 4.3A)
None
FAD  A 501 (-3.1A)
None
None
1.07A 2o4pA-5xgvA:
undetectable
2o4pA-5xgvA:
25.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bac ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Neisseria
gonorrhoeae)
no annotation 5 LEU A 352
ALA A  97
ASP A  96
GLY A   7
VAL A  15
None
1.04A 2o4pA-6bacA:
undetectable
2o4pA-6bacA:
13.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6btm ALTERNATIVE COMPLEX
III SUBUNIT C


(Flavobacterium
johnsoniae)
no annotation 5 LEU C  95
ALA C 115
ILE C 120
ILE C  89
VAL C 235
None
1.09A 2o4pA-6btmC:
undetectable
2o4pA-6btmC:
22.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
7 ARG A  13
LEU A  28
ASP A  30
ALA A  33
ASP A  34
GLY A  58
VAL A  99
None
None
3TL  A 201 (-3.5A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
None
0.56A 2o4pA-6fivA:
15.4
2o4pA-6fivA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
0.89A 2o4pA-6upjA:
18.0
2o4pA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.89A 2o4pA-6upjA:
18.0
2o4pA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
1.49A 2o4pA-6upjA:
18.0
2o4pA-6upjA:
49.49